Clinical Trial Update: The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring how CYP3A4-metabolized and non-CYP3A4 statins influence clopidogrel resistance in patients with cerebral infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Statins

Snippet

Sponsor: The Third Affiliated Hospital of Guangzhou Medical University | Conditions: Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder) | Phase 4 | Status: UNKNOWN